Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mérieux Equity Partners is a leading European investment firm focused on the healthcare and nutrition sectors. Since 2010 it has invested in over 25–40 companies—mainly across Europe—in areas such as diagnostics & therapeutic platforms (biodrugs and medtech), pharma services, life science tools, digital health, animal health and preventive medicine. The firm manages over €1 billion in assets under management as of March 2022. It operates both venture capital funds for early-stage innovation and buyout funds for established businesses.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mérieux Equity Partners.